COLL - Collegium Pharmaceutical, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company which is engaged in developing and planning to commercialize abuse-deterrent products through its patented DETERx platform technology.
IPO Date: May 7, 2015
Sector: Healthcare
Industry: Drug Manufacturers
Market Cap: $741.29M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.53 | 2.51%
Avg Daily Range (30 D): $0.70 | 2.56%
Avg Daily Range (90 D): $0.69 | 2.17%
Institutional Daily Volume
Avg Daily Volume: .33M
Avg Daily Volume (30 D): .76M
Avg Daily Volume (90 D): .44M
Trade Size
Avg Trade Size (Sh.): 77
Avg Trade Size (Sh.) (30 D): 50
Avg Trade Size (Sh.) (90 D): 47
Institutional Trades
Total Institutional Trades: 2,821
Avg Institutional Trade: $1.77M
Avg Institutional Trade (30 D): $2.85M
Avg Institutional Trade (90 D): $2.78M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.96M
Avg Closing Trade (30 D): $4.21M
Avg Closing Trade (90 D): $3.56M
Avg Closing Volume: 69.02K
 
News
Jun 5, 2026 @ 12:00 PM
Collegium Pharmaceutical Reports Inducement Grants...
Source: Na
May 27, 2026 @ 12:00 PM
Collegium to Participate in 2026 Jefferies Global ...
Source: Na
May 12, 2026 @ 11:31 AM
Collegium Completes Acquisition of AZSTARYS® fr...
Source: Benzinga
Mar 31, 2026 @ 1:12 AM
Collegium's General Counsel Trims His Stake as the...
Source: Seena Hassouna
Mar 5, 2026 @ 1:00 PM
Collegium to Present New Real-World Data at PainCo...
Source: Na
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $1.52 $-.46 $.45
Diluted EPS $1.28 $-.46 $.4
Revenue $808.21M $199.88M $193.52M
Gross Profit $485.09M $110.29M $117.25M
Net Income / Loss $47.92M $-15.05M $14.5M
Operating Income / Loss $157.44M $3.7M $30.9M
Cost of Revenue $323.12M $89.59M $76.27M
Net Cash Flow $12.13M $-139.18M $37.4M
PE Ratio